The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders
Brooks M. Hybertson, Bifeng Gao, An Doan
- ISSN / E-ISSN
- — / —
- DOI
- 10.2147/cpaa.s35078 ↗
- Volume · Issue · Pages
- 6 · — · 19-19
- Publisher
- Dove Medical Press Ltd.
- Article URL
- https://doi.org/10.2147/cpaa.s35078 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
01 Feb 2014
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 01 Feb 2014 | OpenAlex |
Keywords (as given): Nrf2 signaling; Nrf2; antioxidant response element; phase II enzymes; cytoprotective genes; chemoprevention; cancer chemotherapy resistance; degenerative diseases; immune disorders; dietary supplements; physical activity; disease prevention
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
- Journal
- Clinical Pharmacology: Advances and Applications
- Publication date used
- 01 Feb 2014 (OpenAlex publication date)
- Applicable HEC period
- None recorded for this date
- Category
- —
- Recognition status
- Unknown (NO_PERIOD_FOR_DATE)
- Source
- —
- Verification status
- Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.
